Curative Ventures V LLC

DALLAS, TX · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 3, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$13.7M2026 Q3
Positions1
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Curative Ventures V LLC reported 1 positions worth $13.7M as of September 30, 2026 (13F filed November 3, 2026). Largest holding: Instil Bio, Inc. (100.0%).

1 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1Instil Bio,Instil Bio$13.7M100.00%1,899,004———

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Curative Ventures V LLC hold as of Q3 2026?

Curative Ventures V LLC reported 1 positions worth $13.7M in its Q3 2026 13F filing. Largest positions: Instil Bio, Inc. (100.0%).

What did Curative Ventures V LLC buy in Q3 2026?

Curative Ventures V LLC opened or added to no positions in Q3 2026.

What did Curative Ventures V LLC sell in Q3 2026?

Curative Ventures V LLC reduced or sold out of no positions in Q3 2026.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.